These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4237624)

  • 1. Plasmatic and platelet anti-plasmins and anti-activators. 3. Results in normal people, in patients and in those with venous thrombosis.
    den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1969 Feb; 21(1):35-41. PubMed ID: 4237624
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmatic and thrombocytic anti-plasmins and anti-activators. II.
    den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1969 Feb; 21(1):26-34. PubMed ID: 4237623
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmatic and platelet anti-plasmins and anti-activators.
    Den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):404-15. PubMed ID: 4232162
    [No Abstract]   [Full Text] [Related]  

  • 4. Antifibrinolysin effect of thrombocytes.
    Schulz K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):263-71. PubMed ID: 4106018
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterio-venous differences in the components of the fibrinolytic enzyme system.
    Ogston D; Ogston CM; Bennett NB
    Thromb Diath Haemorrh; 1966 Jul; 16(1):32-7. PubMed ID: 4229628
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the coagulation and fibrinolytic systems predisposing to thrombosis.
    Nilsson IM
    Acta Chir Scand Suppl; 1968; 387():15-22. PubMed ID: 4240349
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The function of naturally fibrinolysis inhibiting agents in normal plasma and normal thrombocytes].
    den Ottolander GJ; Leijnse B; Cremer-Elferink MM
    Ned Tijdschr Geneeskd; 1968 May; 112(19):920-1. PubMed ID: 4233299
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactate dehydrogenase isoenzymes in thrombocytes in various diseases.
    Knudsen FU; Gormsen J
    Scand J Haematol; 1968; 5(5):361-70. PubMed ID: 4974192
    [No Abstract]   [Full Text] [Related]  

  • 10. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human platelet antiplasmin. Detection and determination of a noncompetitive inhibitor effect of plasmin using a technic with radiofibrinogen].
    Dechavanne M; Lagarde M; Thouverez JP; Viala JJ
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:31-5. PubMed ID: 4271633
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet monoamine oxidase and blood plasma benzylamine oxidase activity in cirrhotic patients.
    Cortesini C; Buffoni F; Ignesti G; Pirisino R; Sestini MC
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):982-6. PubMed ID: 7126373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemostasis disorders in liver cirrhosis].
    Judkiewicz L; Olszañska T; Tomaszewska L
    Pol Tyg Lek; 1973 May; 28(19):708-11. PubMed ID: 4270099
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Natural inhibitors of fibrinolysis and their physiological importance].
    Pastorova VE
    Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrophoretic changes in fibrinogen in liver cirrhosis].
    Ruiz-Reyes G; Labastida-Muñoz H; Ruiz-Argüelles GJ; Sánchez-Fernández M; Landero de Ruiz N
    Gac Med Mex; 1981 Jan; 117(1):31-4. PubMed ID: 7262487
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on blood platelet release reaction. I. Acid phosphatase availability.
    Sack ES; Glanczpigel R
    Medicina (B Aires); 1972; 32(4):373-81. PubMed ID: 4635008
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific determinations of prothrombin for evaluation of liver function.
    Norén I; Blombäck M
    Acta Med Scand; 1972 Mar; 191(3):257-62. PubMed ID: 5033717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Paper and agar electrophoresis results of pathologic plasma proteins with specific reference to fibrinogens].
    Götz H; Moussazadeh M; Reichel H
    Med Welt; 1968 May; 19():1227-32. PubMed ID: 5728822
    [No Abstract]   [Full Text] [Related]  

  • 20. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
    Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
    Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.